The RSU awards, stock option and PSU award were approved by Lifecore’s compensation committee and were granted as inducement equity awards in accordance with Nasdaq Listing Rule 5635(c)(4) under ...

(MENAFN- GlobeNewsWire - Nasdaq) CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated ...

CHASKA, Minn. (AP) — CHASKA, Minn. (AP) — Lifecore Biomedical, Inc. (LFCR) on Thursday reported a loss of $14.8 million in its fiscal third quarter. The Chaska, Minnesota-based company said it ...

While exploring urban mobility solutions, I've encountered a different kind of ride, one that was once designed to keep you riding far, relaxed, and over all sorts of terrain. Oh, and just so we ...

Revenue: US$35.2m (down 1.5% from 3Q 2024). Net loss: US$17.4m (down by 217% from US$14.8m profit in 3Q 2024). US$0.47 loss per share (down from US$0.48 profit in 3Q 2024). Trump has pledged to ...

CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore”) a fully integrated contract development and manufacturing organization ("CDMO”), today announced ...

Good afternoon, and thank you for joining Lifecore's Fiscal 2025 Third Quarter Earnings Call. During the call, all participants will be in a listen-only mode. Now I would like to turn the call ...

In a report released today, Michael Petusky from Barrington maintained a Hold rating on Lifecore Biomedical (LFCR – Research Report). The company’s shares opened today at $6.30. Discover the ...

Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities ...

Backs FY25 adjusted EBITDA view $19M-$21M. The company said, “For the full fiscal year 2025, the company is reiterating its financial guidance and expects revenue to be approximately $126.5 to $ ...